Invesco Comstock Contrarian Equity ETF (BATS:CSTK – Get Free Report) saw a large increase in short interest during the month of October. As of October 15th, there was short interest totaling 7,217 shares, an increase of 83.2% from the September 30th total of 3,939 shares. Approximately 0.2% of the company’s stock are sold short. Based on an average daily trading volume, of 19,916 shares, the days-to-cover ratio is presently 0.4 days.
Invesco Comstock Contrarian Equity ETF Stock Performance
Shares of CSTK opened at $33.43 on Monday. Invesco Comstock Contrarian Equity ETF has a 52 week low of $27.42 and a 52 week high of $34.33. The firm has a market cap of $131.71 million and a P/E ratio of 17.05. The firm’s 50-day simple moving average is $33.35 and its 200 day simple moving average is $31.89.
About Invesco Comstock Contrarian Equity ETF
Invesco Actively Managed Exchange Traded Fund Trust – Invesco Comstock Contrarian Equity ETF is an exchange traded fund launched and managed by Invesco Capital Management LLC. The fund is co-managed by Invesco Advisers, Inc The fund invests in the equity markets. The fund invests directly and through derivatives in stocks of companies across diversified sectors. It invests in value stocks of large-cap companies. Invesco Actively Managed Exchange Traded Fund Trust – Invesco Comstock Contrarian Equity ETF is domiciled in the United States.
Further Reading
- Five stocks we like better than Invesco Comstock Contrarian Equity ETF
- Marvell Eyes a Swing for the AI Networking Fences as Markets Weigh Lumentum Price Tag
- Exxon’s Refining Profits Soared—Did Chevron Get the Same Windfall?
- Eli Lilly’s First Full Medicare Quarter: Is Volume Still Outrunning Price Cuts?
- Oracle’s AI Spending Peak Is in Sight—Can the Stock Recover?
Receive News & Ratings for Invesco Comstock Contrarian Equity ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Invesco Comstock Contrarian Equity ETF and related companies with MarketBeat.com's FREE daily email newsletter.
